{"mainPropery":{"diseaseId":5797,"diseaseName":"AL amyloidosis","hasGardWebPage":true,"isRare":true,"websiteUrl":"https://rarediseases.info.nih.gov/diseases/5797/al-amyloidosis","synonyms":["Primary systemic amyloidosis","Amyloidosis AL","Light chain amyloidosis","Systemic AL amyloidsis","Primary AL amyloidosis","Primary systemic AL amyloidosis","Amyloidosis primary systemic","Primary amyloidosis (Formerly)"],"synonyms-with-source":[{"name":"Primary systemic amyloidosis"},{"name":"Amyloidosis AL"},{"name":"Light chain amyloidosis"},{"name":"Systemic AL amyloidsis"},{"name":"Primary AL amyloidosis"},{"name":"Primary systemic AL amyloidosis"},{"name":"Amyloidosis primary systemic"},{"name":"Primary amyloidosis (Formerly)"}],"identifiers":[]},"diseaseCategories":[],"organizations":[{"resourceID":154,"resourceName":"Amyloidosis Foundation","abbreviation":"","address1":"7151 N. Main Street","address2":"Suite 2","address3":"","address4":"","address5":"","city":"Clarkston","state":"MI","zip":"48346","country":"United States","phone":"","tty":"","tollFree":"877-AMYLOID (1-877-269-5643) ","fax":"","email":"info@amyloidosis.org","url":"http://www.amyloidosis.org/","freeText":""},{"resourceID":625,"resourceName":"Amyloidosis Support Groups Inc.","abbreviation":"","address1":"232 Orchard Drive","address2":"","address3":"","address4":"","address5":"","city":"Wood Dale","state":"IL","zip":"60191","country":"United States","phone":"630-350-7539","tty":"","tollFree":"866-404-7539","fax":"","email":"info@amyloidosissupport.org","url":"https://www.amyloidosissupport.org/","freeText":""},{"resourceID":673,"resourceName":"Amyloidosis Australia, Inc.","abbreviation":"","address1":"131-133 Napier Street","address2":"St. Arnaud,","address3":"Victoria, 3478","address4":"","address5":"","city":"","state":"","zip":"","country":"Australia","phone":"03 5495 1169","tty":"","tollFree":"","fax":"","email":"info@amyloidosis.com.au","url":"http://www.amyloidosis.com.au/","freeText":""},{"resourceID":4220,"resourceName":"Amyloidosis Research Consortium","abbreviation":"","address1":"320 Nevada Street, Suite 210","address2":"","address3":"","address4":"","address5":"","city":"Newton","state":"MA","zip":"02460","country":"United States","phone":"617-467-5170","tty":"","tollFree":"","fax":"","email":"arc@arci.org","url":"https://www.arci.org/","freeText":""}],"resource descriptions":[{"id":8,"resourceId":11,"resourceName":"PubMed","descriptionText":"<a href='http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=DetailsSearch&Term=amyloidosis%5BTitle%5D+AND+%28hasabstract%5Btext%5D+AND+%222003%2F11%2F07%22%5BPDat%5D+%3A+%222008%2F11%2F04%22%5BPDat%5D+AND+%22humans%22%5BMeSH+Terms%5D+AND+English%5Blang%5D+AND+Review%5Bptyp%5D%29' target='_blank'>PubMed</a> is a searchable database of medical literature and lists journal articles that discuss AL amyloidosis. Click on the link to view a sample search on this topic.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":9,"resourceId":12,"resourceName":"ClinicalTrials.gov","descriptionText":"<a href='http://www.clinicaltrials.gov/ct2/results?cond=%22AL+amyloidosis%22' target='_blank'>ClinicalTrials.gov</a> lists trials that are related to AL amyloidosis. Click on the link to go to ClinicalTrials.gov to read descriptions of these studies. <br />\r\n<br />\r\n<em><strong>Please note:</strong>&nbsp;Studies listed on the&nbsp;ClinicalTrials.gov&nbsp;website are listed for informational purposes only; being listed does not reflect an endorsement by GARD or the NIH. We strongly recommend that you talk with a trusted healthcare provider before choosing to participate in any clinical study.</em>","resourceClassificationName":"Research","resourceClassificationSectionName":"Clinical Research Resources"},{"id":336,"resourceId":1154,"resourceName":"RareConnect","descriptionText":"<div style=\"margin-top: 0px; margin-bottom: 0px;\"><a href='https://www.rareconnect.org/en/community/amyloidosis' target='_blank'>RareConnect</a> has an online community for patients&nbsp;and families with this condition so they can connect with others and share&nbsp;their experiences living with a rare disease.&nbsp;The project is a joint collaboration between EURORDIS (European Rare Disease Organisation) and NORD (National Organization for Rare Disorders).</div>","resourceClassificationName":"Organizations","resourceClassificationSectionName":"Social Networking Websites"},{"id":475,"resourceId":1249,"resourceName":"Amyloidosis - The Amyloid Treatment and Research Program at Boston University School of Medicine","descriptionText":"The <a href='http://www.bu.edu/amyloid/about/what/treatments/ ' target='_blank'>Amyloid Treatment and Research Program</a> at Boston University School of Medicine provides information on the treatment of different forms of amyloidosis.","resourceClassificationName":"Treatment","resourceClassificationSectionName":"Management Guidelines"},{"id":477,"resourceId":1249,"resourceName":"Amyloidosis - The Amyloid Treatment and Research Program at Boston University School of Medicine","descriptionText":"The <a href='http://www.mayoclinic.org/amyloidosis/ ' target='_blank'>Mayo Clinic</a> provides information on the diagnosis and treatment of amyloidosis.","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1527,"resourceId":2159,"resourceName":"National Organization for Rare Disorders","descriptionText":"The <a href='http://www.rarediseases.org/rare-disease-information/rare-diseases/byID/22/viewAbstract' target='_blank'>National Organization for Rare Disorders</a> (NORD) has a report for patients and families about this condition. NORD is a patient advocacy organization for individuals with rare diseases and the organizations that serve them.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1529,"resourceId":2128,"resourceName":"MedlinePlus","descriptionText":"<a href='http://www.nlm.nih.gov/MEDLINEPLUS/ency/article/000533.htm' target='_blank'>MedlinePlus</a> was designed by the National Library of Medicine to help you research your health questions, and it provides more information about this topic.\r\n<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1531,"resourceId":2162,"resourceName":"Medscape Reference","descriptionText":"Medscape Reference provides information on this topic. You may need to register to view the medical textbook, but registration is free.<br />\r\n<a href='http://emedicine.medscape.com/article/208839-overview' target='_blank'>Immunoglobulin-Related Amyloidosis</a><br /><a href='http://emedicine.medscape.com/article/1093258-overview' target='_blank'>Primary Systemic Amyloidosis</a><br />","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1563,"resourceId":2167,"resourceName":"National Kidney and Urologic Diseases Information Clearinghouse","descriptionText":"The <a href='https://www.niddk.nih.gov/health-information/kidney-disease/amyloidosis' target='_blank'>National Kidney and Urologic Diseases Information Clearinghouse</a>  (NIDDK) conducts and supports research on a broad spectrum of diseases affecting public health. Click on the link to view information on&nbsp;this topic.","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1628,"resourceId":625,"resourceName":"Amyloidosis Support Groups Inc.","descriptionText":"<a href='http://www.amyloidosissupport.com/AmyloidAware_Booklet.pdf' target='_blank'>Amyloidosis Awareness</a> is an illustrated booklet for patients and physicians developed by Amyloidosis Support Groups Inc. Versions of the booklet are also available in <a href='http://www.amyloidosissupport.com/AmyloidAware_Spanish.pdf' target='_blank'>Spanish</a>&nbsp;and <a href='http://www.amyloidosissupport.com/AmyloidAware_Portuguese.pdf' target='_blank'>Portuguese</a>.","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1707,"resourceId":2165,"resourceName":"Orphanet","descriptionText":"The&nbsp;<a href='http://www.ojrd.com/content/7/1/54/' target='_blank'>Orphanet Journal of Rare Diseases</a> has published an article with information on this condition.&nbsp;This journal is&nbsp;affiliated with the <a href=\"http://www.orpha.net/\" target=\"_blank\">Orphanet</a>&nbsp;reference portal for information on rare diseases and orphan drugs.","resourceClassificationName":"Overview","resourceClassificationSectionName":"Selected Full-Text Journal Articles"},{"id":2135,"resourceId":3342,"resourceName":"Monarch Initiative","descriptionText":"The <a href='https://monarchinitiative.org/disease/OMIM:254500' target='_blank'>Monarch Initiative</a> brings together data about this condition from humans and other species to help physicians and biomedical researchers. Monarch&rsquo;s tools are designed to make it easier to compare the signs and symptoms (phenotypes) of different diseases and discover common features. This initiative is a collaboration between several academic institutions across the world and is funded by the National Institutes of Health. Visit the website to explore the biology of this condition.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"}],"overviewQuestion":{"questionId":1819,"questionText":"What is AL amyloidosis?","answerText":"<strong>AL amyloidosisis</strong> the most common form of amyloidosis,&nbsp;a group of&nbsp;disorders in which an abnormal protein called amyloid builds up in tissues and organs.&nbsp;The signs and symptoms of AL amyloidosis vary among patients because the build up may occur in the tongue, intestines, muscles, joints, nerves, skin, ligaments, heart, liver, spleen, or kidneys. To diagnose AL amyloidosis, healthcare professionals use blood or urine tests to identify signs of amyloid protein and a <a href=\"http://www.nlm.nih.gov/medlineplus/biopsy.html\" target=\"_blank\">biopsy</a> to confirm the diagnosis.&nbsp;Treatment may include <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002324.htm\" target=\"_blank\">chemotherapy</a> directed at the abnormal plasma cells, <a href=\"http://www.mayoclinic.org/tests-procedures/stem-cell-transplant/basics/definition/PRC-20013565?p=1\" target=\"_blank\">stem cell transplantation</a>, or other treatments based on which symptoms have developed.<span style=\"font-size: 14.3999996185303px;\">[3557]</span><br />\r\n[1105]","dateModified":"2015-07-17T00:00:00"},"basicQuestions":[],"references":[],"relatedDiseases":[{"relatedDiseaseId":6611,"relatedDiseaseName":"Hereditary amyloidosis","relation":"Parent","isRare":true,"hasGardPage":true},{"relatedDiseaseId":12739,"relatedDiseaseName":"Secondary glomerular disease","relation":"Parent","isRare":true,"hasGardPage":false}],"gardCases":[{"caseId":41392,"abbreviatedInquiry":"Is it known if Chromosome X or Chromosome 16 are a factor in amyloids?","caseQuestions":[{"questionId":7061,"questionText":"Are anomalies involving chromosomes 16 and X known to be associated with AL amyloidosis?","answerText":"AL amyloidosis is frequently associated with chromosome anomalies. The anomalies that have been described in association with amyloidosis are numberous and varied.&nbsp;As a result, no single chromosome anomaly is characteristic for this condition.[6216]<br><br>One study did find an extra chromosome X (trisomy X) in&nbsp;13% of women and 54% of men with systemic amyloidosis in their study population.[6217] We were not&nbsp;able to&nbsp;find a study which investigated the prevalence of&nbsp;chromosome 16 anomalies.&nbsp;One of the more common&nbsp;chromosome anomalies associated with systemic amyloidosis is a&nbsp;loss of a copy of chromosome 18 (i.e., chromosome 18 monosomy). In one study this anomaly was&nbsp;identifed in 72% of participants.[6216]","dateModified":"2013-09-24T13:58:00","references":[{"referenceId":6216,"authors":"Fonseca R et al","articleTitle":"Chromosomal abnormalities in systemic amyloidosis","bookWebsiteJournalTitle":"Br J Haematol","date":"1998 Dec;103(3):704-10","url":"http://www.ncbi.nlm.nih.gov/pubmed/9858220","dateAccessed":"2013-09-24T00:00:00"},{"referenceId":6217,"authors":"Rajkumar SV","articleTitle":"Clinical presentation, laboratory manifestations, and diagnosis of immunoglobulin light chain (AL) amyloidosis (primary amyloidosis)","bookWebsiteJournalTitle":"UpToDate","date":"2013","authors2":"Basow DS","placeOfPublication":"Waltham, MA","publisher":"UpToDate"}]}]},{"caseId":30882,"abbreviatedInquiry":"What are risk factors for AL amyloidosis?","caseQuestions":[{"questionId":4587,"questionText":"What are risk factors for AL amyloidosis?","answerText":"The exact cause of AL amyloidosis is not known. The condition appears to occur in similar frequencies among people of various races.[3558] It is thought to occur more commonly in men than in women.[3558]&nbsp;AL amyloidosis is a disease of adulthood. The mean age of people at diagnosis of AL amyloidosis is 65 years.[3558] The condition results from an abnormality of plasma cells in the bone marrow. It is closely related to multiple myeloma.[3559] <br><br>You can visit the following link to the National Cancer Institute's Web site to learn more about risk factors for multiple myeloma.<br><a href=\"http://www.cancer.gov/cancertopics/wyntk/myeloma/page3\">http://www.cancer.gov/cancertopics/wyntk/myeloma/page3</a>","dateModified":"2011-06-10T22:46:00","references":[{"referenceId":3558,"authors":"Nyirady J","articleTitle":"Amyloidosis, Primary Systemic","bookWebsiteJournalTitle":"eMedicine","date":"April 2009","url":"http://emedicine.medscape.com/article/1093258-clinical#a0218","dateAccessed":"2011-06-01T00:00:00"},{"referenceId":3559,"authors":"","articleTitle":"Amyloidosis","bookWebsiteJournalTitle":"National Organization of Rare Disorders","date":"","url":"http://www.rarediseases.org/rare-disease-information/rare-diseases/byID/22/viewAbstract","dateAccessed":"2011-06-01T00:00:00"}]}]}],"news":[{"newsId":671,"dateCreated":"2020-05-20T13:39:00","publishDate":"2020-05-22T00:00:00","title":"NIH-Supported Research Survey to Examine Impact of COVID-19 on Rare Diseases Community","description":"The NIH-funded Rare Diseases Clinical Research Network (RDCRN) has launched an <a href=\"https://www.rarediseasesnetwork.org/COVIDsurvey \" target=\"_blank\">online research survey</a> to find out how the COVID-19 pandemic is impacting individuals with rare diseases, their families and their caregivers. Your participation can help the rare disease research community shed light on the needs of people with rare diseases during this and other potential health crises, in addition to informing future research efforts. The survey must be completed by December 15, 2020.","url":"https://www.rarediseasesnetwork.org/COVIDsurvey","lastModified":"2020-11-30T14:44:00","isFeatured":false}],"conferences":[],"phenoTypes":[],"medicalProducts":[],"EncodedName":"AL_amyloidosis"}